Paucine



Compound IDCDAMM02366
Common namePaucine
IUPAC nameN-(4-aminobutyl)-3-(3,4-dihydroxyphenyl)prop-2-enamide
Molecular formulaC13H18N2O3

Experimental data

Retention time1.18
Adduct[M+K]+
Actual mz289.095
Theoretical mz289.095
Error0.2
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.6844

Identifiers and class information

Inchi keyKTZNZCYTXQYEHT-XQRVVYSFSA-N
SmilesOC(=NCCCCN)C=CC1=CC=C(O)C(O)=C1
SuperclassBenzenoids
ClassPhenols

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)10
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)250.297
Computed dipole moment(dipole)3.209
Total solvent accessible surface area (SASA)553.657
Hydrophobic component of SASA (FOSA)184.241
Hydrophilic component of SASA (FISA)221.37
Pie component of the SASA (PISA)148.046
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)904.254
Number of hydrogen bond donors (donorHB)5
Number of hydrogen bond acceptors (accptHB)5
Free energy of solvation of dipole (dip^2/V)0.0113858
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0201936
Globularity descriptor (glob)0.816804
Predicted polarizability in cubic angstroms (QPpolrz)25.027
Predicted hexadecane/gas partition coefficient (QPlogPC16)10.19
Predicted octanol/gas partition coefficient (QPlogPoct)18.082
Predicted water/gas partition coefficient (QPlogPw)13.606
Predicted octanol/water partition coefficient (QPlogPo/w)0.27
Predicted aqueous solubility (QPlogS)-1.254
Conformation-independent predicted aqueous solubility (CIQPlogS)-1.446
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.928
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)19.658
Predicted brain/blood partition coefficient (QPlogBB)-1.853
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)7.83
Predicted skin permeability, log Kp (QPlogKp)-6.18
PM3 calculated ionization potential (IP(ev))8.921
PM3 calculated electron affinity (EA(eV))0.694
Number of likely metabolic reactions (#metab)4
Prediction of binding to human serum albumin (QPlogKhsa)-0.567
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)51.678
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)110.292
Number of nitrogen and oxygen atoms (#NandO)5
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P02766TTRTransthyretinT86462SEA
P05067APPBeta amyloid A4 proteinT87024SEA
P43166CA7Carbonic anhydrase VIIT37541SEA
P23280CA6Carbonic anhydrase VIT06569SEA
Q9ULX7CA14Carbonic anhydrase XIVT31992SEA
P14780MMP9Matrix metalloproteinase 9T54156SEA
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
Q09472EP300Histone acetyltransferase p300T25956SEA
P10636MAPTMicrotubule-associated protein tauT45593SEA
Q04760GLO1Glyoxalase IT88285SEA
Q16236NFE2L2Nuclear factor erythroid 2-related factor 2T88505SEA
P10809HSPD1Mitochondrial matrix protein P1T11283SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T86462DI0026Amyloidosis[ICD-11: 5D00]P02766TTR
T87024DI0025Alzheimer disease[ICD-11: 8A20]P05067APP
T87024DI0122Diagnostic imaging[ICD-11: N.A.]P05067APP
T06569DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P23280CA6
T06569DI0372Seborrhoeic dermatitis[ICD-11: EA81]P23280CA6
T31992DI0046Bacterial infection[ICD-11: 1A00-1C4Z]Q9ULX7CA14
T31992DI0204Inborn metabolism deficiency[ICD-11: 5C50-5C59]Q9ULX7CA14
T54156DI0219Ischaemic/haemorrhagic stroke[ICD-11: 8B20]P14780MMP9
T54156DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P14780MMP9
T54156DI0395Stomach cancer[ICD-11: 2B72]P14780MMP9
T54156DI0419Ulcerative colitis[ICD-11: DD71]P14780MMP9
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T25956DI0346Prostate cancer[ICD-11: 2C82]Q09472EP300
T25956DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q09472EP300
T45593DI0012Acute myeloid leukaemia[ICD-11: 2A60]P10636MAPT
T45593DI0025Alzheimer disease[ICD-11: 8A20]P10636MAPT
T45593DI0265Mild neurocognitive disorder[ICD-11: 6D71]P10636MAPT
T88285DI0210Influenza[ICD-11: 1E30-1E32]Q04760GLO1
T88505DI0038Ataxic disorder[ICD-11: 8A03]Q16236NFE2L2
T11283DI0120Diabetes mellitus[ICD-11: 5A10]P10809HSPD1

Copyright © 2025